Comparison in Levels of Interleukin 6, Ferritine and Neutrophil-Lymphocyte Ratio in COVID-19 Patiens Treated in ICU and Non-ICU
DOI:
https://doi.org/10.33533/jpm.v16i2.4891Keywords:
Interleukin 6, ferritin, neutrophil-lymphocyte ratio, COVID-19Abstract
Inflammation is caused by infectious diseases, including COVID-19. Severe inflammatory responses contribute to weak adaptive immune response, there by resulting in immune response imbalance. Circulating biomarkers can represent inflammation and immune status are potential predictors for the prognosis of COVID-19 patients. Ferritin and interleukin-6 can serve as significant biomarkers in the detection of cytokine storm, systemic inflammation, and the prognosis of COVID-19. Neutrophil-lymphocyte ratio is an independent prognostic biomarker for COVID-19 patients. The aim of this study to determine differences levels of IL-6, ferritin, and NLR in COVID-19 patients treated ICU and non-ICU. This study was comparative cross-sectional design of 62 COVID-19 patients. Research was conducted at the Central Laboratory and Medical Record of Dr. M. Djamil Padang hospital (May-September 2021). Interleukin-6 levels determined the ECLIA methods, ferritin with the ELFA methods, and NLR with calculation methods. Bivariate data were analyzed with Mann-Whitney test. The characteristics of COVID-19 patients treated in ICU: 64.5% male, average age was 53.52(10.71) years, 48.4% death, and non ICU: female 71.0%, average 42.32 (12.22) years, and recovered 100%. The most common comorbid is hypertension. There were significant differences levels of IL-6, ferritin, and NLR in ICU and non-ICU patients with COVID-19 (p<0.001).References
Man MA, Rajnoveanu RM, Motoc NS, Bondor CI, Chis AF, Lesan A, et al. Neutrophil-to-lymphocyte ratio, platelets-to lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients. Plos One journal. 2021; 16(6)
Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng et al. The epidemiology and clinical information about COVID-19. European Journal of Clinical Microbiology & Infectious Diseases. 2020; 39 :1011-19
Kementerian Kesehatan Republik Indonesia. Infeksi Emerging. Media Informasi Resmi Terkini. 2021
Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome (SARS-CoV-2), Medical Virology. 2020; 23-30.
Bhardwaj A, Sapra L, Sainia C, Azama Z, Mishrab P, Vermaa B, Gyan C, Srivastava R. COVID-19: Immunology, Immunopathogenesis and Potential Therapies. International Reviews of Immunology. 2021
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ and Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) In Clinical Review & Education, Amsterdam: JAMA. 2020; E1-13.
Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers Associated With COVID-19 Disease Progression. Critical Reviews In Clinical Laboratory Sciences. Critical reviews in Clinical Laboratory Sciense. 2020. 57(6): 389-399.
Tay MZ, Poh CM, Renia L, Ary PM, Lisa F. The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews, Immunologi. 2020 (20)
Yang AP, Liu JP, Taoc W, Li H .The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 Patients. International Immunopharmacology. 2020; 84: 1-8
Susilo A, Rumende M, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan, et al. Coronavirus Disease 2019: Tinjauan Literatur Terkini pada Jurnal Penyakit Dalam Indonesia. Jakarta: Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia-RSUPN dr. Cipto Mangunkusumo. 2020; 7 (1): 45-67.
Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B et al. COVID-19: Immunopathogenesis and Immunotherapeutics. Signal Transduction And Targeted Therapy.2020; 5(1): 1-8.
Bachini F, Cattaneo GM, Capelli P. Serum Feritin Levels in Inflammation: a Retrospective Comparative Analysis Between COVID-19 and Emergency Surgical non-COVID-19 Patients. World Journal of Emergency Surgery. 2021; (16)
Tanaka T, Narazaki M, Kishimoto T. IL-6 in Inflamation, Immunity, and Disease. Cold Spring Harbor Perspectives In Biology. 2014
Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The Role of Biomarkers In Diagnosis Of COVID-19-A Systematic Review. Life Sciences. 2020; 254:1-12.
Vargas VM and Cortés-Rojo C. Feritin levels and COVID-19. Rev Panam Salud Publica. 2020; 44:e72.1-2.
Melo A, Milby K,Caparroz A, Pinto A, Santos R, Rocha A et al. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis. Plosone. 2021; 16(6)
Mohammedsaeed W, Surrati A. Alnakhli H, Alharbi M, Syeed N.Alteration of Ferritin Levels and Lymphocytes Counts in Saudi Patients with COVID-19 Infection in Al Madinah Al Munawarah. International Journal of Diabetes and Endocrinology. 2020; 5 (4): 61-66.
Ortolan A, Lorenzin M, Felicetti M, Doria A, Ramonda R. Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. International Journal of Infectious Diseases. 2020; 496-504.
Abate BB , Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex Difference In Coronavirus Disease (COVID-19): A Systematic Review And Meta-Analysis. BMJ. 2020
Fan BE, Chong VC, Chan SS,Lim GH, Lim KG, Tan GB. Hematologic parameters in patients with COVID-19 infection. Am J Hematol.2020; 95: E131-53.
Sanyaolu A, Okorie C, Marinkovic A, Patidar A, Younis K, Desai P et al. Comorbidity and Its Impact on Patient with Covid 19. SN Comprehensive Clinical Medicine. 2020; 1-8
Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology. 2021; (64): 36-47.
Raza HA, Sen P, Bhatti OA, Gupta L. Sex hormones, autoimmunity and gender disparity in COVID-19. Rheumatology international. 2021; (41): 1375-86.
Wolfe J, Safdar B, Madsen T, Sethuraman KN, Becker B, Greenberg MR.Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARSCoV-2. Clinical Therapeutics. 2021; 43 (3) : 557-71.
Cheng S, Zhao Y, Wang F, Chen Y, Kaminga AC, Xu H. Comorbidities’ Potential Impacts On Severe And Non-Severe Patients With COVID. Medicine. 2021; 100 (12): 1-12.
Kazancioglu S, Bastug A, Orkun BO, Kemirtlek N, Bodur H. The role of haematological parameters in patients with COVID-19 and influenza virus infection. Epidemiology and Infection. Cambridge University Press.2020; 148: 1-8
Liu X, Wang H, Shi S, Xiao J. Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis. Postgrad Med J. 2021; 0 :1–9.
Comes EA, Haghbayan H. Interleukin-6 in Covid-19: A systematic review and metaanalysis. Rev Med Virol. 2020.
Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, Baildon M, et al. Elevated Levels Of IL-6 And CRP Predict The Need For Mechanical Ventilation In COVID-19. American Academy of Allergy, Asthma & Immunology. 2020; 146 (1) : 128-36.
Deng F, Zhanga L, Lyua L, Lua Z, Gaoa D, Mab X, et al. Increased levels of feritin on admission predicts intensive care unit mortality in patients with COVID-19. Medicina Clinica. 2020;156(7): 324-331
Lin Z, Fei, Yan Y, Chend X, Xue L, Yang M. Serum ferritin as an independent risk factor for severity in COVID-19 patients. Journal of infection.2020
Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Feritin In The Coronavirus Disease 2019 (COVID‐19): A Systematic Review And Meta‐Analysis. J Clin Lab Anal.2020:e23618: 1-18
Shang W, Dong J, Ren Y, Tian M , Li W, Hu J, Li Y. The value of clinical parameters in predicting the severity of COVID‐19. Journal of Medicine Virology. 2020; 92 : 2188–92.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright Notice
All articles submitted by the author and published in the Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, are fully copyrighted by the publication of Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan under the Creative Commons Attribution-NonCommercial 4.0 International License by technically filling out the copyright transfer agreement and sending it to the publisher
Note :
The author can include in separate contractual arrangements for the non-exclusive distribution of rich versions of journal publications (for example: posting them to an institutional repository or publishing them in a book), with the acknowledgment of their initial publication in this journal.
Authors are permitted and encouraged to post their work online (for example: in an institutional repository or on their website) before and during the submission process because it can lead to productive exchanges, as well as earlier and more powerful citations of published works. (See Open Access Effects).
